Showing 421 - 440 results of 3,897 for search 'Lexmark~', query time: 1.68s Refine Results
  1. 421
  2. 422
  3. 423
  4. 424
  5. 425
  6. 426
  7. 427
  8. 428
  9. 429
  10. 430
  11. 431
  12. 432

    Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes by Jakob Grauslund, Andreas Abou Taha, Laleh Dehghani Molander, Ryo Kawasaki, Sören Möller, Kurt Højlund, Lonny Stokholm

    Published 2024-12-01
    “…As it has recently been implied that the use of semaglutide associates with NAION, the aim of the present study was to evaluate this risk prospectively in all persons with type 2 diabetes (T2D) in Denmark. Methods In a five-year longitudinal cohort study, we identified all persons with T2D in Denmark (n = 424,152) between 2018 and 2024. …”
    Get full text
    Article
  13. 433

    Use of 18F-NaF PET in the staging of skeletal metastases of newly diagnosed, high-risk prostate cancer patients: a nationwide cohort study by Christian Torp-Pedersen, Mette Nørgaard, Helle D Zacho, Lars J Petersen, Anna Winther Mogensen, Marie T Pank

    Published 2022-06-01
    “…Objective To determine whether preoperative staging of high-risk prostate cancer with 18F-sodium-fluoride (18F-NaF) positron emission tomography (PET) reduces the risk of skeletal metastases.Design Nationwide, population-based cohort study using real-world data.Setting The study used national health registries, including all sites in Denmark from 2011 to 2018.Participants Newly diagnosed high-risk prostate cancer patients who underwent radical prostatectomy from 2011 to 2018. …”
    Get full text
    Article
  14. 434
  15. 435
  16. 436

    Risk of Subclinical Hypothyroidism in Breast Cancer Patients Treated With CT-Guided Radiation Therapy: A Prospective Observational Study by Amdisen L, Brink C, Lorenzen EL, Roenlev JD, Ewertz M, Cronin-Fenton D

    Published 2025-01-01
    “…Lau Amdisen,1 Carsten Brink,2,3 Ebbe Laugaard Lorenzen,2,3 Jeanette Dupont Roenlev,4 Marianne Ewertz,2 Deirdre Cronin-Fenton1 1Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark; 2Department of Clinical Research, University of Southern Denmark, Odense, Denmark; 3Laboratory of Radiation Physics, Department of Oncology, Odense University Hospital, Odense, Denmark; 4Department of Oncology, Odense University Hospital, Odense, DenmarkCorrespondence: Lau Amdisen, Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Olof Palmes Allé 43-45, Aarhus N, 8200, Denmark, Tel +45 8716 8229, Email amdisen@clin.au.dkPurpose: The thyroid gland is an organ at risk in breast cancer survivors who receive radiation therapy to the supraclavicular lymph nodes. …”
    Get full text
    Article
  17. 437
  18. 438
  19. 439
  20. 440